Skip to content

Clinical trial to evaluate the therapeutic medicine - thippiliyathi chooranam (internal) and valuzhuvai thylam (external) of psoriasis.

An open clinical trial to Evaluate the Safety and Therapeutic Efficacy of THIPPILIYATHI CHOORANAM (Internal) and VALUZHUVAI THYLAM(External) in the management of KALANJAGAPADAI (PSORIASIS).

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/07/004723
Enrollment
40
Registered
2014-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- psoriasis

Interventions

Intervention1: Thippiliyathi Chooranan: It is a poly herbal formulation 2 gm B.d. with gee for 48 days.

Sponsors

National institute of siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Erythematous lesions Itching Scaling Willing to attend OPD or admission in IPD for the trial Willingness for consent Willing to give specimen of blood for the investigation Willing to take photograph before and after treatment

Exclusion criteria

Exclusion criteria: Hypertension Diabetes mellitus Cardiac disease Peptic ulcer HIV Pregnancy and lactation Psoriasis with evidence of any other skin disease Psoriatic arthropathy Evidences of secondary infection in the lesions

Design outcomes

Primary

MeasureTime frame
Reduction of leasion determined by PASI ScoreTimepoint: Clearance of lesions and Reduction of PASI Score from 3,4 to 0,1.

Secondary

MeasureTime frame
Redaction of clinical symptomsTimepoint: 0,1 2 3;the effect of yogatherapy on kalanjagapadaiTimepoint: the effect of yogatherapy on kalanjagapadai

Countries

India

Contacts

Public ContactDrPSamundeeshwari

National Institute of Siddha

gtsiddha60@gmail.com8056074770

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026